Louisiana State Employees Retirement System’s Acadia Pharmaceuticals ACAD Stock Holding History

Louisiana State Employees Retirement System’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Hold	55,500	–	–	0.02%	871
2026 Q1	$1.24M	Sell	55,500 -1,800	-3%	-$43K	0.02%	884
2025 Q4	$1.53M	Sell	57,300 -100	-0.2%	-$2.39K	0.03%	721
2025 Q3	$1.22M	Sell	57,400 -500	-0.9%	-$11.8K	0.02%	885
2025 Q2	$1.25M	Sell	57,900 -100	-0.2%	-$1.86K	0.02%	838
2025 Q1	$963K	Buy	+58,000	New	+$1.05M	0.02%	979

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Louisiana State Employees Retirement System's ACAD Position: Q2 2026 in Review

Louisiana State Employees Retirement System held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 55,500 shares worth $1.4M. The position accounts for 0.02% of the portfolio, ranked #871.

Louisiana State Employees Retirement System first reported a position in ACAD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.53M in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Louisiana State Employees Retirement System held 55,500 shares of Acadia Pharmaceuticals worth $1.4M as of Q2 2026.
Louisiana State Employees Retirement System left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
Acadia Pharmaceuticals made up 0.02% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #871 holding.
Louisiana State Employees Retirement System first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Louisiana State Employees Retirement System's Acadia Pharmaceuticals position peaked at $1.53M in Q4 2025.
354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.